People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aura Biosciences, Inc. | — | Biotechnology | Series C | $198.2M | $2.5B | 2020 |
| Spero Therapeutics, Inc. | — | Biotechnology | Series C | $92.2M | $150.3M | 2017 |
| Artax Biopharma, Inc. | — | Biotechnology | Series B | $48.0M | $75.7M | 2024 |
| Atox Bio Inc. | — | Biotechnology | Series B | $35.1M | $1.3B | 2017 |
| Nexstim Plc | — | Biotechnology | Seed | $3.7M | $166.4M | 2014 |
Casper Breum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Casper Breum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter B. Finn | 2 | 11 |
| Alan Walts | 2 | 3 |
| Javier Garcia | 2 | 3 |
| Casper E. Breum | 2 | 2 |
| David Johnson | 1 | 35 |
| Jean-Francois Formela | 1 | 17 |
| Scott Jackson | 1 | 13 |
| Erez Chimovits | 1 | 7 |
| Terry Gould | 1 | 6 |
| Gino Santini | 1 | 5 |
| Raj Parekh | 1 | 5 |
| Vikas Goyal | 1 | 5 |
| ANKIT MAHADEVIA | 1 | 4 |
| Milind Deshpande | 1 | 4 |
| Daniel Burgess | 1 | 4 |
| Lawrence C. Best | 1 | 4 |
| Pedro Granadillo | 1 | 3 |
| Ken Charhut | 1 | 3 |
| Gino W. Santini | 1 | 3 |
| Peter Wirth | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.